Rezurock is not the kind of medication you casually move from breakfast to bedtime because the bottle happens to be sitting near the coffee maker. Its dose, meal timing, drug interactions, laboratory monitoring, and storage instructions all matter. Fortunately, the standard Rezurock dosage is fairly straightforward for most people: one 200-milligram tablet taken once daily with a meal.
The details become more important when a person takes certain acid-reducing medicines, uses a strong CYP3A inducer, develops significant side effects, or has liver or kidney problems. This guide explains the available form and strength, how to take Rezurock, what to do after a missed dose, and when a healthcare professional may modify or interrupt treatment.
What is Rezurock?
Rezurock is the brand name for belumosudil, an oral kinase inhibitor. In the United States, it is approved for adults and children 12 years of age and older who have chronic graft-versus-host disease, commonly shortened to chronic GVHD, after at least two previous systemic therapies did not work adequately.
Chronic GVHD can occur after an allogeneic stem cell or bone marrow transplant. Donor immune cells begin attacking the recipient’s tissues, potentially affecting the skin, eyes, mouth, lungs, liver, digestive tract, joints, and connective tissue. Rezurock inhibits ROCK2-related signaling involved in inflammatory immune activity and abnormal fibrotic, or scar-forming, processes.
In the clinical study supporting its approval, participants had already received multiple treatments, and many had severe chronic GVHD involving several organs. Rezurock is therefore generally used as part of specialist-managed care rather than as a first treatment immediately after diagnosis.
Rezurock form and strength
Rezurock is available as an oral tablet in one strength: 200 mg. Each tablet contains 200 mg of belumosudil, provided as the mesylate salt. The tablet is pale yellow, film-coated, and oblong. It is marked “KDM” on one side and “200” on the other.
The medication is usually supplied in a 30-count bottle. Because only one commercial tablet strength is available, the standard once-daily regimen normally involves taking one tablet. When a clinician prescribes twice-daily dosing because of a drug interaction, the patient generally takes one 200-mg tablet per dose rather than splitting a tablet.
Can Rezurock tablets be cut or crushed?
No. Rezurock tablets should be swallowed whole with water. They should not be cut, split, crushed, or chewed. In other words, this is not the moment to improvise with a kitchen knife and hope pharmaceutical science appreciates the enthusiasm.
A patient who cannot swallow the tablet whole should contact the prescribing team rather than altering it. Research is examining crushed-tablet administration in selected clinical settings, but that does not change the current FDA-approved instructions for routine use.
What is the usual Rezurock dosage?
The recommended Rezurock dose for chronic GVHD is:
- Adults: 200 mg by mouth once daily with food.
- Children 12 years and older: 200 mg by mouth once daily with food.
- Children younger than 12 years: Safety, effectiveness, and an approved dosage have not been established.
The same standard dose is used for eligible adults and adolescents. The dosage is not routinely calculated according to body weight for patients 12 years and older because population pharmacokinetic data did not show a clinically meaningful effect from age or body weight in this approved population.
Treatment is generally continued until chronic GVHD progresses and requires a new systemic therapy. Patients should keep taking Rezurock as prescribed even when they feel better, unless their healthcare professional instructs them to hold or stop it. Feeling better is welcome news, but it is not an automatic prescription-editing license.
How to take Rezurock correctly
Take each dose with a meal
Rezurock should be taken with a meal at approximately the same time every day. Food meaningfully affects how the body absorbs belumosudil, so the meal instruction is part of the dosing plan, not decorative fine print. The manufacturer’s patient guidance emphasizes that the dose should accompany a real meal rather than a small snack.
A patient might pair the dose with breakfast, lunch, or dinner, depending on the schedule recommended by the care team. The most practical choice is generally a meal that happens consistently. Someone who frequently skips breakfast, for example, may find dinner easier to maintain. The important points are consistency, a proper meal, and adherence to the prescribed schedule.
Swallow it with water
Take the tablet whole with a glass of water. Do not dissolve it, chew it, crush it into food, or place half of it back in the bottle for tomorrow. Patients with swallowing problems should ask whether a pharmacist or transplant specialist can recommend an appropriate strategy.
Use approximately the same time each day
Taking Rezurock at a consistent time supports a regular medication routine and reduces the likelihood of forgotten or accidentally repeated doses. A phone alarm, medication log, or daily pill checklist can help, although the tablet itself should remain in its original moisture-protective bottle until it is time to take it.
What should you do after a missed Rezurock dose?
If a dose is missed and the patient remembers later on the same day, the FDA-approved patient instructions say to take it as soon as it is remembered. The next dose should then be taken at the usual time on the following day.
If the missed dose is not remembered until the next day, skip it and return to the normal schedule. Do not take two doses together, take an extra tablet, or squeeze two doses into one day to “catch up.” Medication arithmetic is not improved by panic.
Anyone who is uncertain about whether a dose was already taken should call the pharmacist or treatment team. Taking another tablet based on a guess could result in an unintended extra dose.
What if too much Rezurock is taken?
A person who takes more Rezurock than prescribed should contact the healthcare provider, Poison Control, or an emergency medical service promptly. Be prepared to report how many tablets were taken and approximately when the exposure occurred.
When is Rezurock taken twice daily?
The standard regimen is once daily, but the prescribing information recommends increasing the dose to 200 mg twice daily when Rezurock is administered with either of the following:
- A proton pump inhibitor, commonly called a PPI.
- A strong CYP3A inducer.
Proton pump inhibitors can reduce belumosudil exposure because the drug has pH-dependent solubility. Strong CYP3A inducers can also reduce exposure by increasing the metabolic activity that clears the medication. In either situation, lower exposure could reduce Rezurock’s effectiveness, which is why the labeled adjustment is an increase to 200 mg twice daily.
This adjustment must be prescribed by a healthcare professional. Patients should not double their dose simply because they recognize a heartburn medicine or another potentially interacting product on their medication list. The prescriber may instead review whether the interacting medicine is necessary, whether an alternative is appropriate, and how the entire regimen should be monitored.
Why a complete medication list matters
Rezurock can interact with more than PPIs and CYP3A inducers. It may affect medicines transported or metabolized through pathways involving BCRP, OATP1B1, CYP1A2, CYP3A, UGT1A1, and P-glycoprotein. In some combinations, the concentration of the other medicine may rise, increasing its risk of adverse effects.
Patients should provide the transplant team and pharmacist with a current list of prescription medicines, over-the-counter drugs, vitamins, herbal products, and supplements. Starting or stopping a medication without discussing it first can change how Rezurock or the other treatment behaves. Even caffeine may deserve a conversation because belumosudil can inhibit CYP1A2, an enzyme involved in caffeine metabolism.
Rezurock dosage adjustments for side effects
Rezurock does not have a lower tablet strength for routine step-down dosing. When a serious adverse reaction occurs, the labeled approach typically involves temporarily holding treatment or permanently discontinuing it rather than having the patient shave a little off the tablet like a block of Parmesan.
Liver-related laboratory abnormalities
The healthcare team should monitor total bilirubin, alanine aminotransferase, or ALT, and aspartate aminotransferase, or AST, at least once a month during treatment. These blood tests help identify possible liver injury before it becomes more severe.
According to the prescribing information, Rezurock should be held for Grade 3 elevations in AST or ALT, defined in the label as 5 to 20 times the upper limit of normal, or for a Grade 2 bilirubin elevation of 1.5 to 3 times the upper limit of normal. Once the results recover to Grade 0 or 1, treatment may be resumed at the recommended dose under medical supervision.
Rezurock should be permanently discontinued for Grade 4 AST or ALT elevations, meaning more than 20 times the upper limit of normal, or Grade 3 or higher bilirubin elevations above three times the upper limit of normal. These are clinician-directed decisions based on laboratory values and standardized toxicity criteria, not symptoms a patient is expected to grade at home.
Other serious adverse reactions
For another Grade 3 adverse reaction, the label recommends holding Rezurock until the reaction improves to Grade 0 or 1 and then resuming at the recommended dose. A Grade 4 adverse reaction generally requires permanent discontinuation.
Common adverse reactions and laboratory abnormalities reported with Rezurock include infections, weakness or fatigue, nausea, diarrhea, shortness of breath, cough, swelling, bleeding, abdominal pain, musculoskeletal pain, headache, high blood pressure, decreased phosphate, increased gamma-glutamyl transferase, and decreased lymphocytes. New, severe, or persistent symptoms should be reported promptly.
Dosage considerations for liver or kidney problems
Liver impairment
No Rezurock dosage adjustment is recommended for mild hepatic impairment classified as Child-Pugh A. The current prescribing information advises avoiding Rezurock in patients with moderate Child-Pugh B or severe Child-Pugh C hepatic impairment who do not have liver GVHD.
Because chronic GVHD itself can involve the liver, treatment decisions may be particularly complex. A transplant specialist must distinguish liver GVHD from other causes of abnormal liver tests and determine whether the expected benefits justify treatment.
Kidney impairment
Rezurock has not been adequately studied in patients with pre-existing severe renal impairment. The prescribing information does not provide a standard reduced dose for this group; instead, clinicians are advised to consider the potential risks and benefits before treatment begins.
Pregnancy, breastfeeding, and fertility considerations
Rezurock can cause fetal harm based on its mechanism and animal study findings. Pregnancy status should be verified before treatment in patients who can become pregnant. Effective contraception is recommended during treatment and for one week after the final dose. Males with female partners who can become pregnant should also use effective contraception during treatment and for one week afterward.
Breastfeeding is not recommended during Rezurock treatment or for one week after the last dose because it is unknown whether belumosudil or its metabolites enter human milk. Animal findings also suggest that the medication may affect male or female fertility, so fertility preservation and family-planning questions are worth discussing before treatment when relevant.
How should Rezurock be stored?
Store Rezurock at controlled room temperature, generally 68°F to 77°F, or 20°C to 25°C. Keep the tablets in their original bottle to protect them from moisture, close the cap tightly after every use, and leave the desiccant packet or drying material inside the container.
Avoid storing the bottle in a humid bathroom, near a sink, or in a hot vehicle. Keep it out of the reach of children and pets. Ask a pharmacist about medication take-back options for expired or unused tablets rather than flushing them or throwing loose tablets into household trash.
Practical experience: making the Rezurock schedule easier to manage
Daily treatment often looks simple on paper: take one tablet with a meal. Real life, however, enjoys adding meetings, medical appointments, nausea, travel, changing prescriptions, and the occasional day when nobody remembers whether lunch actually happened. The most useful “experience” around Rezurock dosing is therefore not a dramatic trick. It is building a boring, repeatable systemand boring is excellent when the alternative is a medication error.
Anchor the dose to a dependable meal
A patient who reliably eats dinner at home may choose dinner as the daily anchor, provided the prescribing team agrees. Someone whose evenings vary but who always eats lunch may prefer midday. The best meal is not necessarily the healthiest-looking meal on social media; it is the one that consistently exists. Because Rezurock should be taken with a meal, tying the tablet to an unpredictable snack can make adherence unnecessarily difficult.
It may help to keep a visible reminder near the dining area while storing the medication itself safely in its original bottle. For example, a note on the refrigerator can say, “Rezurock with dinner,” while the bottle remains in a dry, secure location. This preserves the storage instructions without requiring memory to perform Olympic-level gymnastics.
Use a dose log instead of relying on memory
A simple paper calendar, medication app, or checklist can record the date and time immediately after each dose. This is especially useful when fatigue, disrupted sleep, or several daily medicines make one day blend into the next. The record also helps caregivers avoid the classic exchange: “Did you take it?” followed by, “I think so,” followed by everyone staring thoughtfully at the bottle.
Do not transfer Rezurock into a weekly pill organizer unless a pharmacist specifically approves the plan. The original container and desiccant protect the tablets from moisture. A safer strategy may be to use the organizer for other medicines while placing a reminder card in the Rezurock time slot.
Prepare for medication changes
Acid-reducing drugs are common, and new prescriptions may come from clinicians outside the transplant center. Before starting a PPI, antibiotic, seizure medication, herbal product, or new cancer treatment, patients can make a habit of saying, “I take Rezurockplease check for interactions.” That one sentence gives the pharmacist or prescriber an opportunity to review whether the Rezurock schedule or the new medicine needs adjustment.
Keeping a medication list on a phone and a printed copy in a wallet can make appointments easier. The list should include nonprescription products and supplements, not merely the medicines that arrive in serious-looking pharmacy bottles. Herbal products are still products, and the liver does not award them an exemption for having leaves on the label.
Plan for travel and schedule disruptions
For travel, bring enough tablets for the trip plus a small delay buffer, keep them in the labeled original bottle, and place them in carry-on luggage rather than checked baggage. Maintain the meal-based schedule as consistently as possible. When crossing several time zones, ask the pharmacist or treatment team how to shift the dosing time without accidentally placing two doses too close together.
A missed dose should trigger the approved missed-dose instructions, not improvisation. Take it later only when it is still the same day, then resume the regular schedule the next day. If the next calendar day has already arrived, skip the forgotten tablet. Never compensate with extra doses.
Track symptoms without self-adjusting the dose
A weekly symptom note can help the clinical team evaluate fatigue, diarrhea, nausea, swelling, breathing changes, infection symptoms, bruising, appetite, and chronic GVHD symptoms. Recording when a symptom started, how severe it felt, and whether it affected eating or daily activity is often more useful than writing only “felt bad.”
The key distinction is that tracking supports professional decisions; it does not authorize home dose changes. If laboratory results or side effects require an interruption, restart, or permanent discontinuation, the healthcare team will give specific instructions. Patients should ask for those instructions in writing when possible, especially if several medicines are being adjusted at once.
Frequently asked questions about Rezurock dosing
Can Rezurock be taken on an empty stomach?
No. The approved instructions specify taking Rezurock with a meal. Food affects belumosudil exposure, so patients should not routinely substitute an empty stomach or a tiny snack unless their prescribing professional provides different instructions.
Is the dosage based on body weight?
Not for the approved population. Adults and children 12 years and older generally receive 200 mg once daily, regardless of weight. Drug-interaction adjustments and treatment interruptions may still apply.
Can a patient stop Rezurock when symptoms improve?
Not without speaking to the prescriber. Treatment is generally continued until chronic GVHD progresses and requires another systemic therapy or until toxicity or another clinical reason leads the healthcare team to stop it.
Does everyone taking a PPI need twice-daily Rezurock?
The FDA labeling recommends 200 mg twice daily when Rezurock is coadministered with a proton pump inhibitor. However, the prescriber must confirm the interaction and issue the revised prescription. Patients should not make this change independently.
Conclusion
The standard Rezurock dosage is one 200-mg tablet taken once daily with a meal at approximately the same time each day. The tablet must be swallowed whole, and missed doses should never be replaced with extra tablets. Certain proton pump inhibitors and strong CYP3A inducers can lead to a prescribed increase to 200 mg twice daily, while serious adverse reactions may require a temporary hold or permanent discontinuation.
Because Rezurock has clinically important interactions and requires regular liver monitoring, the medication list deserves a starring role rather than a cameo. Patients should keep their transplant team informed about every prescription drug, over-the-counter product, vitamin, and herbal supplement they use. Consistent meal timing, careful dose tracking, proper storage, and quick communication about new symptoms can make the daily regimen safer and easier to manage.
